Emergent BioSolutions Files 8-K on Financials
Ticker: EBS · Form: 8-K · Filed: Mar 3, 2025 · CIK: 1367644
| Field | Detail |
|---|---|
| Company | Emergent Biosolutions Inc. (EBS) |
| Form Type | 8-K |
| Filed Date | Mar 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations
TL;DR
Emergent BioSolutions dropped an 8-K on March 3rd detailing financial results and operations.
AI Summary
Emergent BioSolutions Inc. filed an 8-K on March 3, 2025, to report on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Delaware and headquartered in Gaithersburg, Maryland.
Why It Matters
This 8-K filing provides crucial updates on Emergent BioSolutions' financial performance and operational status, which can impact investor decisions.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can lead to significant stock price volatility.
Key Players & Entities
- Emergent BioSolutions Inc. (company) — Registrant
- March 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, Maryland (location) — Principal executive offices
- 240-631-3200 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Emergent BioSolutions Inc.'s results of operations and financial condition, along with Regulation FD disclosures and financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 3, 2025.
Where is Emergent BioSolutions Inc. incorporated?
Emergent BioSolutions Inc. is incorporated in Delaware.
What is the address of Emergent BioSolutions Inc.'s principal executive offices?
The address of Emergent BioSolutions Inc.'s principal executive offices is 300 Professional Drive, Gaithersburg, Maryland 20879.
What is the registrant's telephone number?
The registrant's telephone number is (240) 631-3200.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 3, 2025 regarding Emergent BioSolutions Inc. (EBS).